Targeted small molecule therapy and inhibitors for lymphoma
Future Medicinal Chemistry · 2024
DOI: 10.1080/17568919.2024.2359893 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Zhong-Hui Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, P. R. China. Hauptthemen laut MEDLINE: Lymphoma, Antineoplastic Agents, Agammaglobulinaemia Tyrosine Kinase, Small Molecule Libraries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: New-shoot Talents Program of Zhejiang Province, Science and Technology Program of Zhejiang Province (Key Innovative Team), National Undergraduate Training Program for Innovation and Entrepreneurship of China.
Abstract (Originalsprache)
Lymphoma, a blood tumor, has become the ninth most common cancer in the world in 2020. Targeted inhibition is one of the important treatments for lymphoma. At present, there are many kinds of targeted drugs for the treatment of lymphoma. Studies have shown that Histone deacetylase, Bruton's tyrosine kinase and phosphoinositide 3-kinase all play an important role in the occurrence and development of tumors and become important and promising inhibitory targets. This article mainly expounds the important role of these target protein in tumors, and introduces the mechanism of action, structure-activity relationship and clinical research of listed small molecule inhibitors of these targets, hoping to provide new ideas for the treatment of lymphoma. [Box: see text].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, P. R. China.
- Core Facility,The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, P. R. China.
ORCID-Profile: Guo-Wu Rao
Förderung
- New-shoot Talents Program of Zhejiang Province
- Science and Technology Program of Zhejiang Province (Key Innovative Team)
- National Undergraduate Training Program for Innovation and Entrepreneurship of China
Zitieren
APA
Wang, Z. H., Zheng, X., Rao, G. W., & Zheng, Q. (2024). Targeted small molecule therapy and inhibitors for lymphoma. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2024.2359893
Vancouver
Wang ZH, Zheng X, Rao GW, Zheng Q. Targeted small molecule therapy and inhibitors for lymphoma. Future Medicinal Chemistry. 2024. doi:10.1080/17568919.2024.2359893
BibTeX
@article{Wang2024,
author = {Wang, Zhong-Hui and Zheng, Xiang and Rao, Guo-Wu and Zheng, Quan},
title = {Targeted small molecule therapy and inhibitors for lymphoma},
journal = {Future Medicinal Chemistry},
year = {2024},
doi = {10.1080/17568919.2024.2359893}
}
EUVIMED